Logistic regression model of fotemustine toxicity combining independent phase II studies.
about
Survival with dacarbazine and fotemustine in newly diagnosed glioblastoma multiforme.Fotemustine as second-line treatment for recurrent or progressive glioblastoma after concomitant and/or adjuvant temozolomide: a phase II trial of Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).Efficacy and safety of the third-generation chloroethylnitrosourea fotemustine for the treatment of chemorefractory T-cell lymphomas.
P2860
Logistic regression model of fotemustine toxicity combining independent phase II studies.
description
1996 nî lūn-bûn
@nan
1996 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Logistic regression model of fotemustine toxicity combining independent phase II studies.
@ast
Logistic regression model of fotemustine toxicity combining independent phase II studies.
@en
type
label
Logistic regression model of fotemustine toxicity combining independent phase II studies.
@ast
Logistic regression model of fotemustine toxicity combining independent phase II studies.
@en
prefLabel
Logistic regression model of fotemustine toxicity combining independent phase II studies.
@ast
Logistic regression model of fotemustine toxicity combining independent phase II studies.
@en
P2093
P1433
P1476
Logistic regression model of fotemustine toxicity combining independent phase II studies.
@en
P2093
P304
P356
10.1002/(SICI)1097-0142(19961101)78:9<1980::AID-CNCR20>3.3.CO;2-U
P407
P577
1996-11-01T00:00:00Z